 |
|
|
Life Science Analytics and IBC Life Sciences have teamed up to provide complimentary access to the MedTRACK database to pre-registered conference attendees. Registrants can gain access to the MedTRACK database starting on February 12th through March 1st, 2010. This is an incredible value - so don't miss it!
In addition, MedTRACK will launch a conference filter within the database to help delegates plan meetings and conduct due diligence on companies attending the event.
MedTRACK is the most comprehensive database of over 18,000 global private and public biomedical companies. Business development and financial professionals use MedTRACK to obtain data such as pipeline, partnering, and venture information on biomedical companies and products worldwide.
Decision support tools such as R&D intensity, Royalty Explorer, Worldwide Patent Wizard, and Management Contact searching help you to sift through the data and draw conclusions quickly.
|
|
|
 |
|
|
|
|
IBC’s Drug & Biologics Japan
Discovery, Development, Diagnostics, & Beyond
February 22-24, 2010
Sheraton Miyako Hotel
Tokyo, Japan
Register at: www.IBCLifeSciences.com/Japan. Use priority code R10182MED
The Drug & Biologics Japan event aims to address the changing paradigms in Japan's pharmaceutical industry – shifting from small molecules to antibody/protein science and stem cells, from traditional drug discovery to molecularly targeted therapies and personalized medicine strategies. Get first-hand information from over 50 speakers from 10 countries who will share their current strategies, ongoing developments, and proven successes.
|
|
|
Transforming ideas into innovation and bridge the gap between inspiration and implementation |
|
|
|
|
|
|
|
Alternative scaffolds, conjugates, or bispecific antibodies - How you can leapfrog into the current developments |
|
|
|
|
|
|
|
Personalized medicine, pharmacogenomics, biomarkers, and diagnostics - Overcoming challenges to implementation |
|
|
|
|
|
|
|
Science, technology, and therapeutic applications of iPS cells, ES cells, and adult stem cells |
|
|
|
|
|
|
|
Targeting ARQ197, CICs, P2X7, and other novel molecular targets - Working to towards a breakthrough in cancer therapeutics |
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
IBC’s 2nd Annual AsiaTIDES
Oligonucleotide and Peptide Research, Technology and Product Development
February 22-24, 2010
Sheraton Miyako Hotel
Tokyo, Japan
Register at: www.IBCLifeSciences.com/AsiaTIDES. Use priority code R10225MED
AsiaTIDES is the only conference in Japan to learn the latest research, technology, and product development in the field of oligonucleotide and peptide-based therapeutics. Hear updates from the most advanced research companies on new approaches to delivery and formulation and what the most successful commercialization strategies are
Advance your company's research:
The most advanced companies from North America and European will be presenting their new approaches to delivery and formulation
Benchmark your research and development:
Find out what other companies are doing, hear case studies, and success stories presented by speakers from around the world.
Grow your company's development program and increase your knowledge:
Participate in sessions on worldwide regulatory expectations, market landscape, and partnering ideas
Find more information at www.IBCLifeSciences.com/asiatides.
|
|
|
|
|
|
|
Contact MedTRACK:
|
|
|
|
Non Subscribers: |
| |
|
|
To learn more about MedTRACK and schedule a demonstration, please click here. |
| |
Subscribers: |
|
|
|
To view an online demonstration of the conference filter, login by clicking here. |
|
|
|
|
|
|
|
